Seiichi Tamai

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations

Sohei Yamamoto, Hitoshi Tsuda, Masashi Takano et al. · Modern Pathology · 2011 · 259 citations

Oncogenic Agent, Medicine, Pathology +9

The Correlation Between Cytoplasmic Overexpression of Epidermal Growth Factor Receptor and Tumor Aggressiveness

Shigeto Ueda, Sho Ogata, Hitoshi Tsuda et al. · Pancreas · 2004 · 250 citations

Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging

Atsushi Yonemura, Yukihiko Momiyama, Zahi A. Fayad et al. · Journal of the American College of Cardiology · 2005 · 151 citations

Vascular Disease, Cardiovascular Disease, Lipid-lowering Therapy +9

<i>PIK3CA</i> mutation is an early event in the development of endometriosis‐associated ovarian clear cell adenocarcinoma

Sohei Yamamoto, Hitoshi Tsuda, Masashi Takano et al. · The Journal of Pathology · 2011 · 146 citations · Full text

Pathology, Gynecology, Clear Cell Adenocarcinoma +17

Immunohistochemical detection of hepatocyte nuclear factor 1β in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium

Sohei Yamamoto, Hitoshi Tsuda, Shinsuke Aida et al. · Human Pathology · 2007 · 131 citations

Immunohistochemical Detection, Endometrial Clear-cell Adenocarcinomas, Uterine Receptivity +8